Paclitaxel Accord 6 mg/ml koncentrat till infusionsvätska

DRUG3 trials

Sponsors

Karolinska University Hospital, Karolinska Institutet

Conditions

Breast cancer female NOSEarly breast cancerResectable locally advanced squamous cell carcinoma (SCC) of the esophagus

Phase 2

PREDIX Luminal B - Neoadjuvant response-guided treatment of estrogen receptor positive tumors with high proliferation or slow proliferation with metastatic nodes. Part of a platform of translational phase II trials based on molecular subtypes.

Active, not recruitingCTIS2024-519019-32-00

Karolinska University HospitalEarly breast cancer

Start: 2014-12-05Target: 180Updated: 2025-09-03

Phase 3

NEoadjuvant chemoradiotherapy for Esophageal squamous cell carcinoma versus Definitive chemoradiotherapy with salvage Surgery as needed (The NEEDS Trial)

RecruitingCTIS2022-500966-82-00

Karolinska University HospitalResectable locally advanced squamous cell carcinoma (SCC) of the esophagus

Start: 2020-03-11Target: 235Updated: 2025-05-07

Phase 4

TailorDose®-II: Therapeutic dose monitoring of commonly used cytostatic drugs/regimes indicated for breast cancer

Not yet recruitingCTIS2024-514818-12-00

Karolinska InstitutetBreast cancer female NOS

Target: 200Updated: 2025-11-13

Related Papers

Method-Comparison Validation of a Novel Capillary Blood Collection Kit, True Dose® TD-EPI, for Therapeutic Drug Monitoring of Epirubicin

Pharmaceuticals2026-01-28

Development and evaluation of a novel capillary blood collection method for decentralized therapeutic drug monitoring using the True Dose kit.

2025-09-29

Capillary Blood Self-Sampling for Therapeutic Drug Monitoring: A Mixed-Methods Usability Study of the True Dose<sup>®</sup> Kit.

2025-07-09